US 11111272
α4α7 peptide monomer and dimer antagonists
granted A61KA61K38/00A61P
Quick answer
US patent 11111272 (α4α7 peptide monomer and dimer antagonists) held by Protagonist Therapeutics, Inc. expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04